CORC  > 上海健康医学院
MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer
Xie, Manxin; Fu, Ziyi; Cao, Jianxiang; Liu, Yuan; Wu, Jie; Li, Qing; Chen, Yun
刊名BIOMEDICINE & PHARMACOTHERAPY
2018
卷号102
关键词Breast cancer microRNA miR-132 miR-212 PTEN
ISSN号0753-3322
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4265970
专题上海健康医学院
推荐引用方式
GB/T 7714
Xie, Manxin,Fu, Ziyi,Cao, Jianxiang,et al. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer[J]. BIOMEDICINE & PHARMACOTHERAPY,2018,102.
APA Xie, Manxin.,Fu, Ziyi.,Cao, Jianxiang.,Liu, Yuan.,Wu, Jie.,...&Chen, Yun.(2018).MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer.BIOMEDICINE & PHARMACOTHERAPY,102.
MLA Xie, Manxin,et al."MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-kappa B signaling pathway in breast cancer".BIOMEDICINE & PHARMACOTHERAPY 102(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace